| Literature DB >> 25150019 |
Lisa Harlow1, Bernadette R Gochuico2, Ivan O Rosas3, Tracy J Doyle3, Juan C Osorio3, Timothy S Travers4, Carlos C Camacho4, Chester V Oddis5, Dana P Ascherman6.
Abstract
Previous work has demonstrated a correlation between serum anti-citrullinated HSP90 antibodies and rheumatoid arthritis-associated interstitial lung disease (RA-ILD). To further investigate this potential pathogenic relationship, we used ELISA-based techniques to assess anti-citrullinated HSP90 antibody profiles in bronchoalveolar lavage fluid (BALF) of patients with different stages of RA-ILD. 9/21 RA-derived BALF specimens demonstrated IgG and/or IgA antibodies targeting citrullinated HSP90 proteins/peptides, highlighting disease specific responses (with a predilection for RA-ILD) that did not occur in IPF patients (0/5) or healthy control subjects (0/5). Comparison of antibody profiles between BALF and matching serum specimens revealed various recognition patterns favoring predominant production of anti-citrullinated HSP90 antibodies within the lung microenvironment-further supporting the connection between this antibody specificity and parenchymal lung disease. Equally important, qualitative as well as quantitative differences in anti-citrullinated HSP90 profiles between BALF and serum indicate that the lung plays a direct role in shaping the immune repertoire of RA/RA-ILD. Published by Elsevier Inc.Entities:
Keywords: Autoantibodies; Bronchoalveolar lavage fluid; Citrullination; HSP90; Interstitial lung disease; Rheumatoid arthritis
Mesh:
Substances:
Year: 2014 PMID: 25150019 PMCID: PMC4629481 DOI: 10.1016/j.clim.2014.08.004
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969